glucose, (beta-d)-isomer has been researched along with oxidopamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Canuto, KM; Cunha, GM; Leal, LK; Moraes, MO; Nobre Júnior, HV; Oliveira, RA; Pessoa, C; Silveira, ER; Viana, GS | 1 |
| Beitz, AJ; Choi, SM; Han, HJ; Kang, SY; Kim, HW; Kim, KW; Kwon, YB; Lee, HJ; Lee, JH; Roh, DH; Ryu, YH; Yoon, SY | 1 |
| Vieira, A; Yao, Y | 1 |
| Chen, ST; Chen, TY; Lee, MH; Lin, YP; Tseng, HW | 2 |
| Chen, J; Jiang, L; Li, X; Sun, X; Tao, L; Tian, J; Zhang, L; Zhang, X | 1 |
| Greger, H | 1 |
| Dong, H; Dong, M; Li, R; Xu, T; Yu, C; Zhang, X | 1 |
| Feng, D; Huang, L; Lai, J; Lu, F; Nie, T; Tao, K; Wang, B; Yang, Q; Zhang, W | 1 |
| Gu, XS; Hu, LF; Liu, CF; Liu, S; Mao, CJ; Wang, F; Yang, J; Yang, YP; Zhang, CY | 1 |
| Huang, C; Lin, F; Liu, J; Lu, D; Shi, J; Wang, G; Wu, Q; Zhang, F | 1 |
| Haddadi, R; Nadi, F; Poursina, M; Zeraati, F | 1 |
| Dong, HJ; Guo, LP; Li, Y; Liu, DH; Mu, Y; Wang, X; Wang, ZW; Zhou, HL | 1 |
| Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Sun, CH; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL; Zhuang, J | 1 |
| Li, M; Lu, B; Song, H; Xu, T; Zhou, F | 1 |
| An, JP; Dhodary, B; Kim, KS; Lee, CH; Lee, HJ; Lee, JY; Oh, WK; Ryu, YK | 1 |
| Cao, X; Li, Z; Yan, J; Yang, Z; Zhao, N | 1 |
| Alves, C; Goettert, MI; Laufer, S; Pedrosa, R; Pinteus, S; Rehfeldt, SCH; Silva, J | 1 |
1 review(s) available for glucose, (beta-d)-isomer and oxidopamine
| Article | Year |
|---|---|
The diversity of Stemona stilbenoids as a result of storage and fungal infection.
Topics: Antifungal Agents; Glucosides; Humans; Lipoxygenase Inhibitors; Molecular Structure; Oxidopamine; Stemonaceae; Stilbenes; Structure-Activity Relationship | 2012 |
17 other study(ies) available for glucose, (beta-d)-isomer and oxidopamine
| Article | Year |
|---|---|
Amburoside A, a glucoside from Amburanacearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity.
Topics: Animals; Antioxidants; Drug Interactions; Fabaceae; Female; Glucosides; In Vitro Techniques; Mesencephalon; Neurons; Neuroprotective Agents; Neurotoxins; Oxidopamine; Plant Bark; Plant Extracts; Pregnancy; Rats; Rats, Wistar; Sympatholytics | 2005 |
Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect.
Topics: Adrenergic Agents; Animals; Anti-Inflammatory Agents; Bee Venoms; Capsaicin; Disease Models, Animal; Diterpenes; Drug Interactions; Functional Laterality; Gene Expression; Inflammation; Leukocytes; Locus Coeruleus; Mice; Mice, Inbred ICR; Norepinephrine; Oncogene Proteins v-fos; Oxidopamine; Sciatic Neuropathy; Zymosan | 2006 |
Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity.
Topics: Animals; Anthocyanins; Antioxidants; Ascorbic Acid; Cytochromes c; Dopamine; Flavonoids; Glucosides; Kinetics; Mitochondria; Nerve Degeneration; Neurotoxicity Syndromes; Oxidation-Reduction; Oxidopamine; Sympatholytics; Vaccinium | 2007 |
Neural cell protective compounds isolated from Phoenix hanceana var. formosana.
Topics: Animals; Apigenin; Apoptosis; Catechin; Glucosides; Luteolin; Magnoliopsida; Molecular Structure; Neuroprotective Agents; Oxidopamine; PC12 Cells; Plants, Medicinal; Quercetin; Rats; Stereoisomerism; Taiwan | 2009 |
Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.
Topics: Animals; Apoptosis; Cell Nucleus; Cell Survival; Gene Expression Regulation, Enzymologic; Glucosides; Intracellular Space; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxidopamine; PC12 Cells; Rats; Reactive Oxygen Species; Signal Transduction; Stilbenes; Tyrosine | 2011 |
Chemical and biological evaluation of nephrocizin in protecting nerve growth factor-differentiated PC12 cells by 6-hydroxydopamine-induced neurotoxicity.
Topics: Animals; Cell Differentiation; Cell Survival; Dose-Response Relationship, Drug; Glucosides; Luteolin; Molecular Structure; Nerve Growth Factors; Neuroprotective Agents; Oxidopamine; PC12 Cells; Rats; Structure-Activity Relationship | 2012 |
Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway.
Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Cytochromes c; Cytosol; Glucosides; Monoterpenes; NADPH Oxidases; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Oxidopamine; PC12 Cells; Protein Kinase C-delta; Rats; Reactive Oxygen Species; Signal Transduction | 2015 |
Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
Topics: Adrenergic Agents; Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Glucosides; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenols; Rats; Rats, Sprague-Dawley | 2016 |
Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
Topics: Acid Sensing Ion Channels; Animals; Autophagy; Bridged-Ring Compounds; Dopamine; Dopaminergic Neurons; Glucosides; Male; Monoterpenes; Neuroprotective Agents; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Sprague-Dawley | 2016 |
Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity.
Topics: Animals; Dopamine; Glucosides; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Rats; Stilbenes | 2018 |
Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Topics: Animals; Benzyl Alcohols; Catalepsy; Glucosides; Lipid Peroxidation; Male; Microglia; Microinjections; Nitric Oxide; Oxidation-Reduction; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Peroxidase; Rats; Rats, Wistar | 2018 |
Four new phenolic constituents from the rhizomes of Gastrodia elata Blume.
Topics: Animals; Benzyl Alcohols; Cell Death; Cell Line; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Gastrodia; Glucosides; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neurons; Neuroprotective Agents; Oxidopamine; Phenols; Plant Extracts; Rhizome | 2019 |
Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
Topics: Animals; Antioxidants; Apoptosis; Female; Glucosides; Male; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Phenols; Rats; Rats, Wistar; Wnt Signaling Pathway | 2018 |
Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway.
Topics: Animals; Antioxidants; Carboxylic Ester Hydrolases; Dopaminergic Neurons; Gene Expression Regulation, Enzymologic; Glucosides; Larva; Malondialdehyde; Metabolic Networks and Pathways; Motor Activity; NF-E2-Related Factor 2; Oxidopamine; Phenols; Zebrafish; Zebrafish Proteins | 2018 |
Dereplication of Components Coupled with HPLC-qTOF-MS in the Active Fraction of
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Flavones; Gene Expression Regulation; Glucosides; Humans; Humulus; Magnetic Resonance Spectroscopy; Mice; Monoamine Oxidase; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Plant Extracts; Tandem Mass Spectrometry | 2019 |
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucosides; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptor, Insulin; Signal Transduction | 2019 |
Neuroprotective Effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells.
Topics: Acetylcholinesterase; Antioxidants; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Flavones; Glucosides; Humans; Interleukin-10; Lipopolysaccharides; Membrane Potential, Mitochondrial; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Tretinoin; Tumor Necrosis Factor-alpha | 2022 |